Skip to content

USDA Approval for COVID-19 Vaccine

Frankfort, Ky. (August 23, 2021) The following statement, from David Bolt, Chief Executive Officer of the Kentucky Primary Care Association (KPCA), is in response to U.S. Food and Drug Administration approval of the first COVID-19 vaccine.
 
“The U.S. Food and Drug Administration’s approval of the Pfizer COVID-19 vaccine is yet another milestone for the safety and effectiveness of the vaccine,” said David Bolt, Chief Executive Officer of the Kentucky Primary Care Association (KPCA). “Doctors, nurses, and other healthcare professionals agree that people must get vaccinated if we are to end the pandemic and put covid behind us. We encourage everyone who’s eligible for a COVID-19 vaccine to listen to the advice of their trusted healthcare providers, and other healthcare professionals. Schedule your shot today!”
-David Bolt, CEO, Kentucky Primary Care Association
 
The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals. The vaccine has been available since December, 2020.
 
The full USDA release is available here: https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine

Scroll To Top